UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000060704
Receipt number R000069442
Scientific Title Observational study about the relationship between intestinal flora,intestinal barrier and kidney function in the chronic kidney disease patients
Date of disclosure of the study information 2026/02/18
Last modified on 2026/02/18 19:29:07

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Observational study about the relationship between intestinal flora,intestinal barrier and kidney function in the chronic kidney disease patients

Acronym

IFBK-CKD

Scientific Title

Observational study about the relationship between intestinal flora,intestinal barrier and kidney function in the chronic kidney disease patients

Scientific Title:Acronym

IFBK-CKD

Region

Japan


Condition

Condition

chronic kidney disease

Classification by specialty

Nephrology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Investigate the relationship between intestinal flora, metabolite, and factors related with intestinal barrier in the chronic kidney disease (CKD) patients (Stage G1-G5).

Basic objectives2

Others

Basic objectives -Others

It is expected that basic data for inventing the new treatment ways of CKD will be obtained by identifying the relationship between intestinal flora, intestinal barrier and kidney function, and intestinal flora and metabolite related with intestinal barrier and CKD progression.

Trial characteristics_1

Exploratory

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

Investigate the relationship between CKD and intestinal flora, by analyzing CKD Stage, metabolomics of blood, urine and feces, and intestinal flora.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

100 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients in nephrology department of Kyoto University Hospital who agree to join this study.

Key exclusion criteria

Patients with severe digestive diseases, cancer, pregnent, or who take antibiotics, immunosuppressant drugs

Target sample size

180


Research contact person

Name of lead principal investigator

1st name Motoko
Middle name
Last name Yanagita

Organization

Kyoto University

Division name

Department of Nephrology, Graduate School of Medicine

Zip code

606-8507

Address

54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto

TEL

075-751-3860

Email

motoy@kuhp.kyoto-u.ac.jp


Public contact

Name of contact person

1st name Ryo
Middle name
Last name Yamada

Organization

Kyoto University

Division name

Department of Adaptive and Maladaptive Responses in Health and Disease, Graduate School of Medicine

Zip code

606-8507

Address

53 Shogoin Kawahara-cho, Sakyo-ku, Kyoto

TEL

075-366-7482

Homepage URL


Email

ryamada@kuhp.kyoto-u.ac.jp


Sponsor or person

Institute

Kyoto University

Institute

Department

Personal name



Funding Source

Organization

The other

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kyoto University

Address

54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto

Tel

075-751-3111

Email

ryamada@kuhp.kyoto-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW

京都府


Institutions

Institutions

京都大学医学部附属病院


Other administrative information

Date of disclosure of the study information

2026 Year 02 Month 18 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2025 Year 04 Month 04 Day

Date of IRB

2025 Year 04 Month 09 Day

Anticipated trial start date

2025 Year 04 Month 04 Day

Last follow-up date

2027 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Observational study: Prospective case series study.
Research registration: -2027/3/31.
Planned number of people: 180.
Measurement target: blood, urine, feces.
Others: questionnaire, body composition evaluation


Management information

Registered date

2026 Year 02 Month 18 Day

Last modified on

2026 Year 02 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000069442